Key facts
- It has raised $15.0M; the latest was Angel (individual) in Jun 2025.
- Notable investors include Creative Destruction Lab, MedTech Innovator, Life Sciences BC, Providence Health Care Ventures, Adara Venture Capital — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Total Flow Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Total Flow Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Total Flow Medical
Developer of novel medical devices designed to prevent injury to patients requiring extracorporeal circulation. The company's initial product is an easy-to-use cannula for use during minimally invasive cardiopulmonary bypass surgery, enabling patients to eliminate the chances of injury and death during invasive cardiopulmonary bypass surgery.
- Sector
- Healthcare
- HQ
- Vancouver, Canada
- Founded
- 2019
- Employees
- 6
- Website
- totalflowmedical.com/
- Ownership
- Privately Held (backing)
Total Flow Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Total Flow Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Total Flow Medical in its N-PORT filings yet. We sweep new filings monthly.